Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

CSF proteome profiling reveals biomarkers to discriminate dementia with Lewy bodies from Alzheimer´s disease
Marta del Campo, Lisa Vermunt, Carel F.W. Peeters, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 32

Showing 1-25 of 32 citing articles:

Comprehensive proteomics of CSF, plasma, and urine identify DDC and other biomarkers of early Parkinson’s disease
Jarod Rutledge, Benoit Lehallier, Pardis Zarifkar, et al.
Acta Neuropathologica (2024) Vol. 147, Iss. 1
Open Access | Times Cited: 25
Proteomic changes in Alzheimer disease associated with progressive Aβ plaque and tau tangle pathologies
Alexa Pichet Binette, Chris Gaiteri, Malin Wennström, et al.
Nature Neuroscience (2024) Vol. 27, Iss. 10, pp. 1880-1891
Open Access | Times Cited: 16
Neuroimaging and fluid biomarkers in Parkinson’s disease in an era of targeted interventions
Angeliki Zarkali, George E. Thomas, Henrik Zetterberg, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 15
Multiplex cerebrospinal fluid proteomics identifies biomarkers for diagnosis and prediction of Alzheimer’s disease
Yu Guo, Shi-Dong Chen, Jia You, et al.
Nature Human Behaviour (2024) Vol. 8, Iss. 10, pp. 2047-2066
Closed Access | Times Cited: 13
A critical appraisal of blood-based biomarkers for Alzheimer’s disease
Simone Lista, Mark Mapstone, Filippo Caraci, et al.
Ageing Research Reviews (2024) Vol. 96, pp. 102290-102290
Closed Access | Times Cited: 12
The Link Between Matrix Metalloproteinases and Alzheimer’s Disease Pathophysiology
Dominika Radošinská, Jana Radošinská
Molecular Neurobiology (2024)
Open Access | Times Cited: 10
Body fluid multiomics in 3PM-guided ischemic stroke management: health risk assessment, targeted protection against health-to-disease transition, and cost-effective personalized approach are envisaged
Ruofei Chen, Xiaoyan Wang, Na Li, et al.
The EPMA Journal (2024) Vol. 15, Iss. 3, pp. 415-452
Open Access | Times Cited: 8
Novel blood‐based proteomic signatures across multiple neurodegenerative diseases
Rory Durcan, Amanda Heslegrave, Peter G. Swann, et al.
Alzheimer s & Dementia (2025) Vol. 21, Iss. 3
Open Access | Times Cited: 1
Proteomic comparison between non‐purified cerebrospinal fluid and cerebrospinal fluid‐derived extracellular vesicles from patients with Alzheimer's, Parkinson's and Lewy body dementia
Yael Hirschberg, Natalia Valle‐Tamayo, Oriol Dols‐Icardo, et al.
Journal of Extracellular Vesicles (2023) Vol. 12, Iss. 12
Open Access | Times Cited: 22
DOPA-decarboxylase is elevated in CSF, but not plasma, in prodromal and de novo Parkinson’s disease
Ellen Appleton, Shervin Khosousi, Michael Ta, et al.
Translational Neurodegeneration (2024) Vol. 13, Iss. 1
Open Access | Times Cited: 4
Current trends in blood biomarkers detection and neuroimaging for Parkinson's disease
Ni Liu, Tianjiao Zhang, Wei Zhao, et al.
Ageing Research Reviews (2025), pp. 102658-102658
Closed Access
Increased plasma DOPA decarboxylase levels in Lewy body disorders are driven by dopaminergic treatment
Katharina Bolsewig, Eline A.J. Willemse, Pascual Sánchez‐Juan, et al.
Nature Communications (2025) Vol. 16, Iss. 1
Open Access
A comprehensive view of the molecular features within the serum and serum EV of Alzheimer's disease
Jiayi Zhang, Xiaoqin Cheng, Anqi Hu, et al.
The Analyst (2025)
Closed Access
THOP1 Is Entailed in a Genetic Fingerprint Associated with Late-Onset Alzheimer’s Disease
Sharlee Climer
Biomolecules (2025) Vol. 15, Iss. 3, pp. 337-337
Open Access
A mini review of transforming dementia care in China with data-driven insights: overcoming diagnostic and time-delayed barriers
Pan Lu, Xiaolu Lin, Xiaofeng Liu, et al.
Frontiers in Aging Neuroscience (2025) Vol. 17
Open Access
Cerebrospinal Fluid Phosphoproteome Characterization Using Titanium Dioxide Enrichment and High-Resolution LC-MS/MS
Elena Anaya‐Cubero, Adriana Cortés, Mercedes Lachén‐Montes, et al.
Methods in molecular biology (2025), pp. 77-87
Closed Access
Lycium barbarum polysaccharide ameliorates corticosterone-induced cognition decline with modulation of CRHR1
Xiaoxiao Shi, Xiaofeng Tian, Bin He, et al.
Brain Research Bulletin (2025), pp. 111346-111346
Open Access
Plasma proteome profiling identified biomarkers for the differential diagnosis and molecular staging of neurodegenerative dementias
G. Bellomo, Lisa Vermunt, Sjors G. J. G. In ‘t Veld, et al.
(2025)
Closed Access
Increased CSF DOPA Decarboxylase Correlates with Lower DaT‐SPECT Binding: Analyses in Biopark and PPMI Cohorts
Shervin Khosousi, Andrea Sturchio, Ellen Appleton, et al.
Movement Disorders (2024) Vol. 39, Iss. 10, pp. 1881-1885
Open Access | Times Cited: 3
Anthropometric and Demographic Features Affect the Interpretation of Cerebrospinal Fluid Biomarkers in Patients with Different Dementia Syndromes and Cognitively Healthy Adults
Fabricio Ferreira de Oliveira, Marjorie Câmara Miraldo, Eduardo Ferreira de Castro-Neto, et al.
NeuroMolecular Medicine (2024) Vol. 26, Iss. 1
Closed Access | Times Cited: 2
Corticotropin-releasing hormone as a candidate biomarker for parkinsonian disorders
Bárbara Fernandes Gomes, Atul Kumar, Nicholas J. Ashton, et al.
Brain Communications (2024) Vol. 6, Iss. 6
Open Access | Times Cited: 2
Microglia-Associated Neuroinflammation in Alzheimer’s Disease and Its Therapeutic Potential
Siddharth Shah, Hritvik Jain
Neuroglia (2024) Vol. 5, Iss. 4, pp. 452-466
Open Access | Times Cited: 2
Fluid and tissue biomarkers in Parkinson’s disease: Immunodetection or seed amplification? Central or peripheral?
Cèlia Painous, Manel Fernández, J. Pérez Pérez, et al.
Parkinsonism & Related Disorders (2023) Vol. 121, pp. 105968-105968
Closed Access | Times Cited: 5
Microglia-Associated Neuroinflammation in Alzheimer’s Disease
Siddharth Shah, Hritvik Jain
(2024)
Open Access | Times Cited: 1
CSF proteins of inflammation, proteolysis and lipid transport define preclinical AD and progression to AD dementia in cognitively unimpaired individuals
Marta del Campo, Carlos Gonzalez Quesada, Lisa Vermunt, et al.
Molecular Neurodegeneration (2024) Vol. 19, Iss. 1
Open Access | Times Cited: 1
Page 1 - Next Page

Scroll to top